share_log

HC Wainwright & Co. Reiterates Buy on ProPhase Labs, Maintains $14 Price Target

Benzinga ·  Jun 2, 2023 03:35

HC Wainwright & Co. analyst Yi Chen reiterates ProPhase Labs (NASDAQ:PRPH) with a Buy and maintains $14 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment